Are androgen receptor variants a substitute for the full-length receptor?
about
Prostate cancer stem cells: the role of androgen and estrogen receptorsProstate Cancer Stem Cells: Research AdvancesEmerging data on androgen receptor splice variants in prostate cancerRegistered report: androgen receptor splice variants determine taxane sensitivity in prostate cancerIdentification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening.BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patientsPROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer.BAP18 coactivates androgen receptor action and promotes prostate cancer progression.A novel variant of androgen receptor is associated with idiopathic azoospermiaNovel Nine-Exon AR Transcripts (Exon 1/Exon 1b/Exons 2-8) in Normal and Cancerous Breast and Prostate Cells.Food components and contaminants as (anti)androgenic molecules.Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells.The Y-located proto-oncogene TSPY exacerbates and its X-homologue TSPX inhibits transactivation functions of androgen receptor and its constitutively active variants.6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer Cells.Combination of carmustine and selenite effectively inhibits tumor growth by targeting androgen receptor, androgen receptor-variants, and Akt in preclinical models: New hope for patients with castration resistant prostate cancer.Androgen receptor-related diseases: what do we know?Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer.RNA splicing and splicing regulator changes in prostate cancer pathologyAndrogen Signaling in Prostate Cancer.Rationale for the development of alternative forms of androgen deprivation therapy.Association of AR-V7 and Prostate-Specific Antigen RNA Levels in Blood with Efficacy of Abiraterone Acetate and Enzalutamide Treatment in Men with Prostate Cancer.Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer Irradiation.Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer.Combination treatment with docetaxel and histone deacetylase inhibitors downregulates androgen receptor signaling in castration-resistant prostate cancer.Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer.Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF.Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer.DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7.ACK1/TNK2 Regulates Histone H4 Tyr88-phosphorylation and AR Gene Expression in Castration-Resistant Prostate Cancer.Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.Longer trinucleotide repeats of androgen receptor are associated with higher testosterone and low oxytocin levels in diabetic premature ejaculatory dysfunction patients.The mediator complex in genomic and non-genomic signaling in cancer.Targeting Splicing in Prostate Cancer.Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progression
P2860
Q26778415-D6E70C45-B078-46AB-BBEA-B2A98640EEF8Q26998435-C1C4B39E-9912-42D6-8DB4-E61B89390509Q28077830-09DBB67F-E796-458F-823E-26E6E06EFE4FQ28607383-E7F479FD-F264-46D2-90BE-EDB5C94FFFB1Q36147506-95EA16BF-B8D6-4F87-B6F0-F58A87932FBCQ36905832-2D0401F2-B112-4FF9-A179-F68A218A34EEQ37065079-2571BE09-F488-434C-929E-A106DE47A18EQ37294780-E2DCA2C2-9F32-47F4-BE25-0220679D47A5Q37297454-359E12F0-37FF-40D8-B79F-FE03B8074605Q37631437-1EE8610B-DCD9-445C-9BF0-FEBBC2E1B4E8Q37645540-F709EC07-C216-4AD0-9B75-37210351C1EEQ37665251-CA646972-E364-478B-9468-21AB32166F45Q38717520-F78489D1-A810-4FCE-8726-2FC9A1120640Q38719143-FD992D6A-E2A8-4EBD-A3E1-21869F2BED37Q38769775-6B8E3157-9BF6-4D5F-8DAF-1D1A3E36624EQ38780007-0B4AF580-14DD-460D-88DE-1916F46E1942Q38943216-9C32F5FE-BB39-4D7D-968D-0956A2054655Q39223617-FB577847-3283-4C17-AF49-613C86A28C4DQ39227656-AA639843-F98C-46EF-99E4-8CF4252B6E22Q39342369-64F79C72-42CE-4169-B5AD-C7A65853C1ECQ40395168-B24F06AE-820B-4578-BD2A-AA1886257BE7Q45960111-BEB0D8D7-1A74-4C14-B7E5-620A27E56A47Q47197872-97577271-7822-4A58-B652-43F52FCA0E32Q47433115-B134350A-CC3E-4AC7-8980-D09310F09BE3Q47696958-200BD24C-EC91-4F30-BE90-18BC8AA27C07Q47820506-32CBCE33-06AD-4971-A6B1-80A9D97C7A04Q48229904-2391F4D9-DA41-4461-8EDF-A9BE777A9159Q49712140-F3CF7EEE-2835-4236-A007-57462A6EC920Q50946916-08A30B42-D2F8-4AFB-BF6D-57799CE5A7A3Q51556940-2E53FD04-4620-4782-9378-8B4E86D927CFQ52349523-A6F9E931-AB40-4498-B6C7-71EC6CC01EC6Q52430211-FC6475A0-DB5E-4E2A-A800-B18D07C21182Q55128284-A91C75E6-680E-4E76-8BBE-3A18FDD261F6Q59132279-6DD38336-13C4-4FC9-8EF0-FBCEC6321273
P2860
Are androgen receptor variants a substitute for the full-length receptor?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Are androgen receptor variants a substitute for the full-length receptor?
@en
type
label
Are androgen receptor variants a substitute for the full-length receptor?
@en
prefLabel
Are androgen receptor variants a substitute for the full-length receptor?
@en
P2093
P2860
P356
P1476
Are androgen receptor variants a substitute for the full-length receptor?
@en
P2093
Donald J Tindall
Travis Van der Steen
P2860
P2888
P304
P356
10.1038/NRUROL.2015.13
P407
P577
2015-02-10T00:00:00Z
P5875
P6179
1005325657